- Published on
Infectious Disease And Microbiology – Exanthem Subitum (Roseola Infantum)
Exanthem subitum, also known as roseola infantum or sixth disease, is a common, benign, self-limiting viral illness of early childhood. It is most often caused by human herpesvirus 6B (HHV-6B), although human herpesvirus 7 (HHV-7) may also be responsible.
Epidemiologically, the disease occurs worldwide and primarily affects children between 6 months and 3 years of age, with about 90% of cases occurring before age 2. By the age of 3, nearly all children have been exposed, with antibody prevalence approaching 100%. Maternal antibodies protect infants initially but decline by 6 months, after which susceptibility increases. HHV-7 tends to affect slightly older children and may be associated with a higher risk of febrile seizures.
Human herpesvirus 6B accounts for approximately 10–45% of febrile illnesses in young children. A small proportion of individuals (around 1%) are born with chromosomally integrated HHV-6, though the clinical significance remains unclear.
Currently, there are no specific preventive measures for primary infection. Prophylaxis may be considered in high-risk populations such as bone marrow transplant recipients.
Pathophysiologically, after primary infection, the virus establishes latency in various tissues including lymphoid organs, saliva, and the central nervous system. It infects multiple cell types such as CD4+ T lymphocytes, monocytes, macrophages, endothelial and epithelial cells, and astrocytes. Reactivation can occur, particularly in immunocompromised individuals.
Etiologically, HHV-6 exists as two variants, HHV-6A and HHV-6B, which are now considered distinct viruses. HHV-6 is closely related to cytomegalovirus (CMV). HHV-7 is another causative agent of roseola-like illness.
Clinically, the incubation period is approximately 10–14 days. In children, the disease typically presents with the abrupt onset of high fever (often up to 41°C), lasting 3–5 days. Despite the high fever, the child usually appears relatively well. As the fever subsides, a characteristic maculopapular rash appears in some cases (about 10%), beginning on the trunk and spreading to the face and limbs. The rash is pink, nonpruritic, transient, and resolves within 1–2 days without desquamation.
Associated symptoms may include mild upper respiratory features, cervical lymphadenopathy, and occasionally gastrointestinal symptoms such as diarrhea or vomiting. Febrile seizures occur in about 10% of cases. In infants, a bulging anterior fontanelle may be noted. In rare cases, especially in immunocompromised patients, complications such as encephalitis may occur.
In adults, primary infection or reactivation may present as a mononucleosis-like illness, upper respiratory infection, pneumonia, or hepatitis. In transplant patients, HHV-6 is an important cause of bone marrow suppression and interstitial pneumonitis.
On physical examination, key findings include high fever with abrupt resolution, followed by a transient rash, cervical lymphadenopathy, and generally preserved overall condition.
Laboratory findings may show leukopenia, lymphocytopenia, atypical lymphocytes, and sometimes mild hepatitis, especially in adults. The erythrocyte sedimentation rate is typically normal, and cerebrospinal fluid findings are usually normal unless there is CNS involvement. Diagnosis can be confirmed by PCR, viral isolation, or serology, although routine testing is not usually required in typical cases.
The differential diagnosis includes other viral infections such as CMV, adenovirus, measles, rubella, and viral upper respiratory infections, as well as serious bacterial infections. A key distinguishing feature is the child’s relatively well appearance despite high fever and the appearance of rash after defervescence.
Treatment is supportive in most cases. Antipyretics such as acetaminophen (paracetamol), adequate hydration, and comfort measures are usually sufficient. Antiviral therapy (e.g., ganciclovir or foscarnet) is reserved for severe cases or immunocompromised patients, particularly transplant recipients.
The prognosis is excellent, as the disease is self-limiting. Most children recover completely without complications.
Complications are rare but may include febrile seizures, and in immunocompromised patients, more severe outcomes such as pneumonia, hepatitis, bone marrow suppression, encephalitis, or aseptic meningitis.
Infectious Disease And Microbiology – Exanthem Subitum (Roseola Infantum)
Exanthem subitum, also known as roseola infantum or sixth disease, is a common, benign, self-limiting viral illness of early childhood. It is most often caused by human herpesvirus 6B (HHV-6B), although human herpesvirus 7 (HHV-7) may also be responsible.
Epidemiologically, the disease occurs worldwide and primarily affects children between 6 months and 3 years of age, with about 90% of cases occurring before age 2. By the age of 3, nearly all children have been exposed, with antibody prevalence approaching 100%. Maternal antibodies protect infants initially but decline by 6 months, after which susceptibility increases. HHV-7 tends to affect slightly older children and may be associated with a higher risk of febrile seizures.
Human herpesvirus 6B accounts for approximately 10–45% of febrile illnesses in young children. A small proportion of individuals (around 1%) are born with chromosomally integrated HHV-6, though the clinical significance remains unclear.
Currently, there are no specific preventive measures for primary infection. Prophylaxis may be considered in high-risk populations such as bone marrow transplant recipients.
Pathophysiologically, after primary infection, the virus establishes latency in various tissues including lymphoid organs, saliva, and the central nervous system. It infects multiple cell types such as CD4+ T lymphocytes, monocytes, macrophages, endothelial and epithelial cells, and astrocytes. Reactivation can occur, particularly in immunocompromised individuals.
Etiologically, HHV-6 exists as two variants, HHV-6A and HHV-6B, which are now considered distinct viruses. HHV-6 is closely related to cytomegalovirus (CMV). HHV-7 is another causative agent of roseola-like illness.
Clinically, the incubation period is approximately 10–14 days. In children, the disease typically presents with the abrupt onset of high fever (often up to 41°C), lasting 3–5 days. Despite the high fever, the child usually appears relatively well. As the fever subsides, a characteristic maculopapular rash appears in some cases (about 10%), beginning on the trunk and spreading to the face and limbs. The rash is pink, nonpruritic, transient, and resolves within 1–2 days without desquamation.
Associated symptoms may include mild upper respiratory features, cervical lymphadenopathy, and occasionally gastrointestinal symptoms such as diarrhea or vomiting. Febrile seizures occur in about 10% of cases. In infants, a bulging anterior fontanelle may be noted. In rare cases, especially in immunocompromised patients, complications such as encephalitis may occur.
In adults, primary infection or reactivation may present as a mononucleosis-like illness, upper respiratory infection, pneumonia, or hepatitis. In transplant patients, HHV-6 is an important cause of bone marrow suppression and interstitial pneumonitis.
On physical examination, key findings include high fever with abrupt resolution, followed by a transient rash, cervical lymphadenopathy, and generally preserved overall condition.
Laboratory findings may show leukopenia, lymphocytopenia, atypical lymphocytes, and sometimes mild hepatitis, especially in adults. The erythrocyte sedimentation rate is typically normal, and cerebrospinal fluid findings are usually normal unless there is CNS involvement. Diagnosis can be confirmed by PCR, viral isolation, or serology, although routine testing is not usually required in typical cases.
The differential diagnosis includes other viral infections such as CMV, adenovirus, measles, rubella, and viral upper respiratory infections, as well as serious bacterial infections. A key distinguishing feature is the child’s relatively well appearance despite high fever and the appearance of rash after defervescence.
Treatment is supportive in most cases. Antipyretics such as acetaminophen (paracetamol), adequate hydration, and comfort measures are usually sufficient. Antiviral therapy (e.g., ganciclovir or foscarnet) is reserved for severe cases or immunocompromised patients, particularly transplant recipients.
The prognosis is excellent, as the disease is self-limiting. Most children recover completely without complications.
Complications are rare but may include febrile seizures, and in immunocompromised patients, more severe outcomes such as pneumonia, hepatitis, bone marrow suppression, encephalitis, or aseptic meningitis.
0 Comments
